Wall Street Analysts See Cardinal (CAH) as a Buy: Should You Invest?

2026-02-27 05:36:22

Abstract generation in progress

Wall Street analysts currently rate Cardinal Health (CAH) as a “Strong Buy” with an average brokerage recommendation (ABR) of 1.25. However, the article advises investors against relying solely on these recommendations due to potential positive bias from brokerage firms. Instead, it suggests using the Zacks Rank, which is based on earnings estimate revisions, as a more reliable indicator, noting that CAH currently holds a Zacks Rank #2 (Buy) due to optimistic earnings estimate revisions.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes